Hello, Guest
Login
Sign Up
 
 

OTC Stock Picks Issues a Trend Analysis Report on Hot Penny Stocks - MFTH, AHFD, ZPPB, AMBS

 
 
Repost This

Stamford, CT -- (SBWIRE) -- 01/15/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on Hot Penny Stocks poised to breakout. Our newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. These are the awesome penny stocks that the ‘underground penny stock experts’ brag about in our penny stock blogs.

Medisafe 1 Technologies Corp (OTC:MFTH) is trading with the upsurge of 29.63%, along with the trading price of $0.0035 currently while its today’s opening price was $0.00.

MFTH recently gained a volume of 20.18 million shares, while its average volume is 2.05 million shares. The 52 week price range of the company is $0.00 - $0.04 while today, up until 11.37 AM, its minimum price was $0.00.

The Company’s 6 month’s performance gave a gaining overview as it rose 25%, while in its last 5 days, its performance remained in the green with the surge of 118.75%.

What MFTH’s Charts Are Signaling for Traders? Find Out Here

Active Health Foods, Inc. (OTC:AHFD) recently soared 20.00% after opening at $0.00. Its current trading price is $0.0012 in the current session, as the stock gained total volume of 24.01 million shares currently, whereas its average volume is 14.71 million shares.

The Company’s most recent highest price in today’s trading session is $0.00 while its minimum price up till now remained $0.00. Last 5 day’s performance of the company remained in the red with the plunge of -25%. In itslast three months, AHFD reported a drop of -25%.

How Should Investors Trade AHFD Now? Don’t Miss out on a Special Trend Analysis

Active Health Foods, a development stage company, intends to sell its products to retailers, including health food stores, grocery retail outlets, gyms and convenience stores, as well as to distributors.

Zippy Bags Inc (OTC:ZPPB) opening price for today was $0.09, whereas currently it is trading at $0.279. If we look at its current volume, it is 6.99 million, whereas its average volume is 8,976.00 million shares.

Its overall previous 5 day’s trend is optimistic with a 80.67% gain and its overall year to date performance is surging more than 100.74%. ZPPB’s total outstanding shares are 91.25 million and its total market capitalization stands at $24.73 million, whereas its 52 week price range is $0.09 - $5.00.

Is ZPPB a Solid Investment at These Levels? Read This Report For Details

AMARANTUS BIOSCIENCES INC (OTC:AMBS) opened day trade at $0.11, showed a downtrend and reached the price of $0.108 recently with the loss of -2.71%. Overall trading volume of the shares is 6.2 million during the early hours of trading while its average volume is 22.78 million shares. AMBS’s overall market capitalization is $24.67 million.

Can Investors Bet on AMBS after this Stock update? Find out in this Research Report

If we look at the previous 5 day’s performance of the company, it shows a downward momentum with the loss of more than -28%. Also its last one month of trading shows a gain of 147.59%.

Amarantus BioScience, Inc., a development-stage biotechnology company, has a collaboration agreement with Banyan Biomarkers for the treatment of TBI based on its MANF proprietary anti-apoptotic therapeutic protein.

About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.

Disclaimer
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and the company's website, but this should not be construed as a recommendation to buy or sell.